ArticleiScience2025
Rapid diffused optical imaging for accurate 3D estimation of subcutaneous tissue features.
Article in iScience, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- CW-fDOT with a standard optical brain model: improving hemodynamic sensitivity and functional localization.Neurophotonics · 2026Article
- Development of a statistically standardized optical digital wrist model through integrated MRI-diffuse optical imaging methodology.Journal of biomedical optics · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Conventional light imaging in living tissues is limited to depths under 100 μm by the significant tissue scattering. Consequently, few commercial imaging devices can image tissue lesions beneath the surface, or measure their invasion depth, critical in dermatology. We present 3D-multisite diffused optical imaging (3D-mDOI) an approach that combines photon migration techniques from diffuse optical tomography, with automated controls and image analysis techniques for estimating lesion's depth via its optical coefficients. 3D-mDOI is a non-invasive, low-cost, fast, and contact-free instrument capable of estimating subcutaneous tissue structures volumes through multisite-acquisition of re-emitted light diffusion on the sample surface. It offers rapid estimation of Breslow depth, essential for staging melanoma. To standardize the performance, 3D-mDOI employs customized calibrations using physical tissue phantoms, to explore the system's 3D reconstruction capabilities. We find that 3D-mDOI can reconstruct lesions up to 5 mm below the surface, requiring ∼300 s of computation time.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.